Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  milodistim
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Phase III Randomized Study of PIXY321 vs GM-CSF for Mobilization of Hematopoietic Progenitors in Women with Metastatic Breast Carcinoma (Summary Last Modified 03/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058
Phase I/II Study of PIXY321 (GM-CSF/IL-3 S. cerevisiae Fusion Protein) in Combination with CTX/CBDCA in Patients with Advanced Epithelial Ovarian Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: AECM-9202054, NCI-V92-0080
Phase II Comparative Study of CBDCA/TAX/PIXY321 with vs without PIXY321 Prechemotherapy Hematopoietic Stimulation for Gynecologic Malignancies (Summary Last Modified 03/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-93083, NCI-T93-0132D, T93-0132
Phase I Study of IL-3/GM-CSF Fusion Protein (PIXY321) and CBDCA in Patients with Advanced Cancer (Summary Last Modified 03/94)
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-9108A, NCI-92-C-0079A, NCI-T91-0213N, T91-0213
Phase I Study of PIXY321 Following ICE (IFF/CBDCA/VP-16) in Children with Recurrent Solid Tumors
Phase: Phase I
Type: Treatment
Status: Closed
Age: 1 to 21 at entry
Sponsor: NCI
Protocol IDs: CCG-0924
Start Over